Radiopharmaceuticals Market Growth Driven by Rising Demand for Targeted Cancer Therapy
Nuclear Medicine Drugs: Powering Modern Diagnostics and Therapy in the Radiopharmaceuticals Market Nuclear medicine drugs , commonly known as radiopharmaceuticals, are a specialized class of medicinal compounds that contain radioactive isotopes. These drugs are revolutionizing modern healthcare by enabling both precise disease diagnosis and targeted treatment at the molecular level. Unlike conventional drugs that treat symptoms, nuclear medicine drugs work by targeting specific organs, tissues, or cellular receptors, allowing physicians to detect and treat diseases with remarkable accuracy. Global Asia Pacific Radiopharmaceuticals Market size and share is currently valued at USD 2,086.31 million in 2024 and is anticipated to generate an estimated revenue of USD 5,532.66 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 10.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025...